Skip to main content
Erschienen in: World Journal of Surgery 4/2010

01.04.2010

Validating a Simple Scoring System to Predict Malignancy and Invasiveness of Intraductal Papillary Mucinous Neoplasms of the Pancreas

verfasst von: Sang H. Shin, Duck J. Han, Kwan T. Park, Young H. Kim, Jae B. Park, Song C. Kim

Erschienen in: World Journal of Surgery | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

The objective of the present study was to identify reliable preoperative factors predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm (IPMN) of the pancreas and the effectiveness of a diagnostic scoring system based on these factors.

Methods

Between August 1994 and December 2007, 204 patients underwent pancreatic resection for IPMN at a single institute. Medical records were reviewed retrospectively, and a new diagnostic scoring system for predicting malignant IPMN preoperatively was designed.

Results

Univariate analysis revealed nine significant predictors of both malignant and invasive IPMN: age ≥60 years, history of pancreatitis, presence of mural nodule(s), diameter of main pancreatic duct (MPD) >6 mm, main duct or mixed type, total bilirubin >1.2 mg/dl, CA-19-9 >37 U/ml, tumor location in the pancreatic head, and tumor size >30 mm. Multivariate analysis showed that age, pancreatitis, mural nodule(s), and MPD diameter were independent predictors of invasive IPMN, and that all these parameters, plus elevated carbohydrate antigen-19-9 (CA-19-9), were independent predictors of malignant IPMN. A scoring system based on these five factors, each assigned 1 point, and with a cut-off of 3 points, could predict malignant IPMN with a sensitivity of 50.7% and a specificity of 90.1%. The 5-year survival rates of patients with benign and malignant IPMN were 95.0% and 64.0%, respectively.

Conclusions

Our scoring system using five independent factors (age ≥60 years, history of pancreatitis, presence of mural nodule(s), elevated level of CA-19-9, and MPD diameter >6 mm) may be helpful for predicting malignancy and postoperative survival.
Literatur
1.
Zurück zum Zitat Ohhashi K, Murakami Y, Maruyama M et al (1982) Four cases of mucin producing cancer of the pancreas on specific findings of the papilla of Vater. Prog Dig Endosc 20:348–351 Ohhashi K, Murakami Y, Maruyama M et al (1982) Four cases of mucin producing cancer of the pancreas on specific findings of the papilla of Vater. Prog Dig Endosc 20:348–351
2.
Zurück zum Zitat Klöppel G, Solcia E, Longnecker DS et al (1996) Histological typing of tumors of the exocrine pancreas. In: World Health Organization international histologic classification of tumors, 2nd edn. Springer-Verlag, Berlin Klöppel G, Solcia E, Longnecker DS et al (1996) Histological typing of tumors of the exocrine pancreas. In: World Health Organization international histologic classification of tumors, 2nd edn. Springer-Verlag, Berlin
3.
Zurück zum Zitat Wilentz RE, Iacobuzio-Donahue CA, Argani P et al (2000) Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res 60:2002–2006PubMed Wilentz RE, Iacobuzio-Donahue CA, Argani P et al (2000) Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res 60:2002–2006PubMed
4.
Zurück zum Zitat Hruban RH, Adsay NV, Albores-Saavedra J et al (2001) Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 25:579–586CrossRefPubMed Hruban RH, Adsay NV, Albores-Saavedra J et al (2001) Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 25:579–586CrossRefPubMed
5.
Zurück zum Zitat Tanaka M, Chari S, Adsay V et al (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6:17–32CrossRefPubMed Tanaka M, Chari S, Adsay V et al (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6:17–32CrossRefPubMed
6.
Zurück zum Zitat Nakagohri T, Kenmochi T, Kainuma O et al (2000) Inferior head resection of the pancreas for intraductal papillary mucinous tumors. Am J Surg 179:482–484CrossRefPubMed Nakagohri T, Kenmochi T, Kainuma O et al (2000) Inferior head resection of the pancreas for intraductal papillary mucinous tumors. Am J Surg 179:482–484CrossRefPubMed
7.
Zurück zum Zitat Murakami Y, Uemura K, Yokoyama Y et al (2004) Pancreatic head resection with segmental duodenectomy for intraductal papillary mucinous tumors of the pancreas. J Gastrointest Surg 8:713–719CrossRefPubMed Murakami Y, Uemura K, Yokoyama Y et al (2004) Pancreatic head resection with segmental duodenectomy for intraductal papillary mucinous tumors of the pancreas. J Gastrointest Surg 8:713–719CrossRefPubMed
8.
Zurück zum Zitat Solcia E, Capella C, Kloppel G (1997) Armed Forces Institute of Pathology. In: Atlas of tumor pathology: tumors of the pancreas, 3rd edn. American Registry of Pathology in collaboration with Armed Forces Institute of Pathology, Washington, DC Solcia E, Capella C, Kloppel G (1997) Armed Forces Institute of Pathology. In: Atlas of tumor pathology: tumors of the pancreas, 3rd edn. American Registry of Pathology in collaboration with Armed Forces Institute of Pathology, Washington, DC
9.
Zurück zum Zitat Sugiyama M, Izumisato Y, Abe N et al (2003) Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg 90:1244–1249CrossRefPubMed Sugiyama M, Izumisato Y, Abe N et al (2003) Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg 90:1244–1249CrossRefPubMed
10.
Zurück zum Zitat Wiesenauer CA, Schmidt CM, Cummings OW et al (2003) Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms. Arch Surg 138:610–617CrossRefPubMed Wiesenauer CA, Schmidt CM, Cummings OW et al (2003) Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms. Arch Surg 138:610–617CrossRefPubMed
11.
Zurück zum Zitat Salvia R, Fernandez-del Castillo C, Bassi C et al (2004) Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 239:678–685CrossRefPubMed Salvia R, Fernandez-del Castillo C, Bassi C et al (2004) Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 239:678–685CrossRefPubMed
12.
Zurück zum Zitat Sohn TA, Yeo CJ, Cameron JL et al (2004) Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 239:788–797; discussion 797–789CrossRefPubMed Sohn TA, Yeo CJ, Cameron JL et al (2004) Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 239:788–797; discussion 797–789CrossRefPubMed
13.
Zurück zum Zitat Murakami Y, Uemura K, Hayashidani Y et al (2007) Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas. J Gastrointest Surg 11:338–344CrossRefPubMed Murakami Y, Uemura K, Hayashidani Y et al (2007) Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas. J Gastrointest Surg 11:338–344CrossRefPubMed
14.
Zurück zum Zitat Bassi C, Sarr MG, Lillemoe KD et al (2008) Natural history of intraductal papillary mucinous neoplasms (IPMN): current evidence and implications for management. J Gastrointest Surg 12:645–650CrossRefPubMed Bassi C, Sarr MG, Lillemoe KD et al (2008) Natural history of intraductal papillary mucinous neoplasms (IPMN): current evidence and implications for management. J Gastrointest Surg 12:645–650CrossRefPubMed
15.
Zurück zum Zitat Kim SC, Park KT, Lee YJ et al (2008) Intraductal papillary mucinous neoplasm of the pancreas: clinical characteristics and treatment outcomes of 118 consecutive patients from a single center. J Hepatobiliary Pancreat Surg 15:183–188CrossRefPubMed Kim SC, Park KT, Lee YJ et al (2008) Intraductal papillary mucinous neoplasm of the pancreas: clinical characteristics and treatment outcomes of 118 consecutive patients from a single center. J Hepatobiliary Pancreat Surg 15:183–188CrossRefPubMed
16.
Zurück zum Zitat Nagai K, Doi R, Kida A et al (2008) Intraductal papillary mucinous neoplasms of the pancreas: clinicopathologic characteristics and long-term follow-up after resection. World J Surg 32:271–278CrossRefPubMed Nagai K, Doi R, Kida A et al (2008) Intraductal papillary mucinous neoplasms of the pancreas: clinicopathologic characteristics and long-term follow-up after resection. World J Surg 32:271–278CrossRefPubMed
17.
Zurück zum Zitat Nara S, Onaya H, Hiraoka N et al (2008) Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases. Pancreas 38:8–16CrossRef Nara S, Onaya H, Hiraoka N et al (2008) Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases. Pancreas 38:8–16CrossRef
18.
Zurück zum Zitat Sugiyama Matomi Y (1998) Intraductal papillary mucinous tumors of the pancreas: imaging studies and treatment strategies. Ann Surg 228:685–691CrossRef Sugiyama Matomi Y (1998) Intraductal papillary mucinous tumors of the pancreas: imaging studies and treatment strategies. Ann Surg 228:685–691CrossRef
19.
Zurück zum Zitat Falconi M, Salvia R, Bassi C et al (2001) Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas. Br J Surg 88:376–381CrossRefPubMed Falconi M, Salvia R, Bassi C et al (2001) Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas. Br J Surg 88:376–381CrossRefPubMed
20.
Zurück zum Zitat Kanazumi N, Nakao A, Kaneko T et al (2001) Surgical treatment of intraductal papillary-mucinous tumors of the pancreas. Hepatogastroenterology 48:967–971PubMed Kanazumi N, Nakao A, Kaneko T et al (2001) Surgical treatment of intraductal papillary-mucinous tumors of the pancreas. Hepatogastroenterology 48:967–971PubMed
21.
Zurück zum Zitat Chari ST, Yadav D, Smyrk TC et al (2002) Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 123:1500–1507CrossRefPubMed Chari ST, Yadav D, Smyrk TC et al (2002) Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 123:1500–1507CrossRefPubMed
22.
Zurück zum Zitat Nakagohri T, Asano T, Kenmochi T et al (2002) Long-term surgical outcome of noninvasive and minimally invasive intraductal papillary mucinous adenocarcinoma of the pancreas. World J Surg 26:1166–1169CrossRefPubMed Nakagohri T, Asano T, Kenmochi T et al (2002) Long-term surgical outcome of noninvasive and minimally invasive intraductal papillary mucinous adenocarcinoma of the pancreas. World J Surg 26:1166–1169CrossRefPubMed
23.
Zurück zum Zitat Raimondo M, Tachibana I, Urrutia R et al (2002) Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 97:2553–2558CrossRefPubMed Raimondo M, Tachibana I, Urrutia R et al (2002) Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 97:2553–2558CrossRefPubMed
24.
Zurück zum Zitat Niedergethmann M, Grutzmann R, Hildenbrand R et al (2008) Outcome of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas (IPMN): a 10-year experience. World J Surg 32:2253–2260CrossRefPubMed Niedergethmann M, Grutzmann R, Hildenbrand R et al (2008) Outcome of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas (IPMN): a 10-year experience. World J Surg 32:2253–2260CrossRefPubMed
25.
Zurück zum Zitat Sohn TA, Yeo CJ, Cameron JL et al (2001) Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg 234:313–321CrossRefPubMed Sohn TA, Yeo CJ, Cameron JL et al (2001) Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity. Ann Surg 234:313–321CrossRefPubMed
26.
Zurück zum Zitat Maire F, Hammel P, Terris B et al (2002) Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut 51:717–722CrossRefPubMed Maire F, Hammel P, Terris B et al (2002) Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut 51:717–722CrossRefPubMed
27.
Zurück zum Zitat Shimada K, Sakamoto Y, Sano T et al (2006) Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma. Pancreas 32:281–287CrossRefPubMed Shimada K, Sakamoto Y, Sano T et al (2006) Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicopathologic comparison with a common type of invasive ductal carcinoma. Pancreas 32:281–287CrossRefPubMed
28.
Zurück zum Zitat Woo SM, Ryu JK, Lee SH et al (2008) Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma. Pancreas 36:50–55CrossRefPubMed Woo SM, Ryu JK, Lee SH et al (2008) Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma. Pancreas 36:50–55CrossRefPubMed
29.
Zurück zum Zitat Murakami Y, Uemura K, Sudo T et al (2009) Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma. J Surg Oncol 100:13–18CrossRefPubMed Murakami Y, Uemura K, Sudo T et al (2009) Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma. J Surg Oncol 100:13–18CrossRefPubMed
Metadaten
Titel
Validating a Simple Scoring System to Predict Malignancy and Invasiveness of Intraductal Papillary Mucinous Neoplasms of the Pancreas
verfasst von
Sang H. Shin
Duck J. Han
Kwan T. Park
Young H. Kim
Jae B. Park
Song C. Kim
Publikationsdatum
01.04.2010
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 4/2010
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-010-0416-5

Weitere Artikel der Ausgabe 4/2010

World Journal of Surgery 4/2010 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.